Please ensure Javascript is enabled for purposes of website accessibility

Why LifeStance Health Group Stock Is Crashing Today

By Cory Renauer – Aug 12, 2021 at 12:22PM

Key Points

  • LifeStance Health reported second-quarter earnings after the bell closed on Wednesday.
  • A wider-than-expected net loss and soft growth expectations in the earnings report were a big disappointment.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The mental health service provider surprised investors with heavy operating losses.

What happened

Shares of LifeStance Health Group (LFST 2.88%), a provider of mental health services, were tanking today in response to a disappointing second-quarter earnings report. The stock was down 47.3% as of 11:57 a.m. EDT on Thursday.

So what 

Mental health services have been one of Teladoc Health's (TDOC 0.69%) strongest growth drivers over the past several quarters. As a focused provider of in-person and online mental health services, investors were expecting a strong performance from LifeStance Health after it raised over $800 million in an IPO this June.

A distraught-looking woman holding her temples while looking at a computer.

Image source: Getty Images.

During the first three months of 2021, LifeStance Health's operations lost less than $1 million after bringing in $143 million in top-line revenue. The stock is tanking today partly because second-quarter revenue that rose just 12% sequentially to an annualized $642 million didn't keep pace with operating expenses that surged 44% over the same period. 

Now what

LifeStance Health also disappointed investors with soft guidance for the second half of 2021. Management told investors to expect top-line revenue to reach $668 million to $678 million.

LifeStance Health used a large chunk of its IPO proceeds to pay down existing debts. As a result, there was just $276 million in cash and cash equivalents on its balance sheet at the end of June. With this in mind, it's probably a good idea to watch this company's story play out from a safe distance.

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Stocks Mentioned

LifeStance Health Group, Inc. Stock Quote
LifeStance Health Group, Inc.
$5.71 (2.88%) $0.16
Teladoc Health Stock Quote
Teladoc Health
$29.20 (0.69%) $0.20

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.